Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activityRyotaro Iwasaki, Takeshi Miyamoto, Ken Ninomiya et al.|Biochemical and Biophysical Research Communications|2008Cited by 57
Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitisMayu Morita, Takeshi Miyamoto, Takatsugu Oike et al.|Scientific Reports|2017Cited by 56
Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jawTomoya Soma, Takeshi Miyamoto, Ryotaro Iwasaki et al.|Journal of Bone and Mineral Metabolism|2020Cited by 39
Osteonecrosis development by tooth extraction in zoledronate treated mice is inhibited by active vitamin D analogues, anti-inflammatory agents or antibioticsTomoya Soma, Takeshi Miyamoto, Ryotaro Iwasaki et al.|Scientific Reports|2022Cited by 23
Smad4 is required to inhibit osteoclastogenesis and maintain bone massMayu Morita, Takeshi Miyamoto, Shigeyuki Yoshida et al.|Scientific Reports|2016Cited by 22